Lotan Amit, Bonne Omer, Abramowitz Eitan G
a Hadassah - Hebrew University Medical Center , Jerusalem , Israel.
Int J Clin Exp Hypn. 2015;63(3):294-308. doi: 10.1080/00207144.2015.1031547.
Impaired attention may impede learning of adaptive skills in ADHD. While manipulations that reduce competition between attentional processes, including hypnosis, could boost learning, their feasibility in ADHD is unknown. Because hypnotic phenomena rely on attentional mechanisms, the authors aimed to assess whether stimulants could enhance hypnotizability in ADHD. In the current study, stimulant-naïve patients seeking treatment for ADHD-related symptoms were assessed with the Stanford Hypnotic Susceptibility Scale (SHSS) at baseline and during methylphenidate treatment. Methylphenidate dose and SHSS increase were negatively correlated with baseline SHSS scores. Upon reaching effective doses, mean SHSS scores increased significantly. All patients who had been poorly hypnotizable at baseline demonstrated moderate-to-high hypnotizability at follow-up. The data support methylphenidate enhancement of hypnotizability in ADHD, thus highlighting novel treatment approaches for this disabling disorder.
注意力受损可能会妨碍多动症患者学习适应性技能。虽然包括催眠在内的减少注意力过程之间竞争的操作可以促进学习,但其在多动症中的可行性尚不清楚。由于催眠现象依赖于注意力机制,作者旨在评估兴奋剂是否能增强多动症患者的催眠易感性。在当前研究中,对未服用过兴奋剂、因多动症相关症状寻求治疗的患者,在基线期和哌甲酯治疗期间使用斯坦福催眠易感性量表(SHSS)进行评估。哌甲酯剂量与SHSS得分增加呈负相关,与基线SHSS得分相关。达到有效剂量后,平均SHSS得分显著增加。所有在基线期催眠易感性较差的患者在随访时均表现出中度至高催眠易感性。数据支持哌甲酯增强多动症患者的催眠易感性,从而突出了针对这种致残性疾病的新治疗方法。